Zilovertamab vedotin (MK 2140) in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Early results from the phase 2 waveLINE-004 study.


Ozcan M., Lee S. T., Mensah F., Modi D., Fossa A., Kim W. S., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.41, sa.16, 2023 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 41 Sayı: 16
  • Basım Tarihi: 2023
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
  • Ankara Üniversitesi Adresli: Evet